OutSee raises £1.8m seed funding to enhance its AI-based predictive genomics technology, targeting disease discovery and partnerships in biotech and pharma.

Jun 24, 2025•23 days ago

Amount Raised

£1.8 Million

Round Type

seed

CambridgeArtificial IntelligenceBiotechnology

Description

OutSee has successfully raised £1.8 million in seed funding to support its innovative AI-based predictive genomics technology. The funds will enable the company to expand its target discovery program and forge new partnerships with pharmaceutical and biotech firms. This funding is part of OutSee's broader growth strategy focused on advancing therapeutic discovery and development. The company has previously secured over £500k in grants from Innovate UK for precision medicine.

Company Information

Company

OutSee

Location

Cambridge, England, United Kingdom

About

OutSee is a pioneering company in the field of predictive genomics, utilizing an AI-based approach to discover new targets for drug development. Their proprietary Nomaly technology enables the prediction of disease and phenotype directly from a single genome. By using hypothesis-free, predictive modeling, OutSee aims to uncover underlying biological mechanisms that modulate disease. The company focuses on CNS, rare, and metabolic diseases while collaborating with leading pharma and biotech companies.

OutSee raises £1.8m seed funding to enhance its AI-based predictive genomics technology, targeting disease discovery and partnerships in biotech and pharma.

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information